Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...

Serplulimab significantly improved event-free survival in gastric cancer, showing potential as a neoadjuvant/adjuvant monotherapy. The combination with chemotherapy achieved a pathologic complete ...

Dr Ashwani Kumar, Dr Updesh Kumar World Anesthesia Day is observed annually on October 16th to mark a transformative ...

Defining the role of joint replacement in modern orthopedic care.

The perioperative enfortumab vedotin plus pembrolizumab (EV-P) substantially increased the frequency of adverse events (AEs), ...

Excessive Daytime Sleepiness (EDS) in older adults (60+) who undergone non-cardiac surgery is linked to a greater cognitive ...

When the organization now called the European Society for Medical Oncology (ESMO) opens its 50th anniversary Congress ...

Data from NIAGARA supported the FDA’s approval of neoadjuvant durvalumab in combination with gemcitabine and cisplatin, ...

Lifebox and Smile Train bring critical anesthesia monitors to Ugandan hospitals Kampala, Uganda | PATRICIA AKANKWATSA | In a ...

DelveInsight's Liposarcoma Market Insights report includes a comprehensive understanding of current treatment practices, ...

NYU Grossman School of Medicine’s General Surgery Residency in Manhattan provides the skills and expertise needed to ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...